Blood tests could reduce lung cancer deaths, study finds - Biomarkers found in the blood can reveal changes in the body that ...

The blood test for those at high risk of lung cancer could lead to earlier detection and a "major reduction" in deaths, a ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

Artificial Intelligence Blood Test Provides a Reliable Way to Identify Lung Cancer June 6, 2024 — Using artificial intelligence technology to identify patterns of DNA fragments associated with ...

Oxford, UK and Toronto-based OXcan has secured over $11 million USD in Series A funding to develop and deploy its ...

The Nodify CDT test measures levels of seven autoantibodies associated with lung cancer that can be detected in blood samples of patients with indeterminate lung nodules. Prior studies have ...

Groundbreaking research from the University of St Andrews School of Medicine has found that biomarker testing in individuals ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer ... from patients' airways and blood, finding distinct changes ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...